You may have seen articles in the media over the past few days reporting that medicines containing phenylpropanolamine (PPA) are being withdrawn in the United States (US). This follows the results of a study that suggests use of PPA may be associated with haemorrhagic stroke, particularly when used in slimming treatments. This letter is to keep you informed of the current situation relating to the UK use of PPA containing products (a list of which is attached).
Eskornade capsules - 30 Spansule
Triogesic tablets
Triominic tablets
MU-CRON tablets
Aller-eze Plus
Day Nurse
Day Nurse capsules
Contac 400
Boots prolonged release cold capsules
Benylin day and night cold treatment
Sinutab
Dimotapp Elixir Paediatric
Dimotapp LA Tablets
Dimotapp Elixir
After looking at most of these UK OTC products it seems that the Phenylpropanolamine Hydrochloride has been replaced with Pseudoephedrine Hydrochloride or will be soon.
Terrible news for amphetamine makers, great news for methedrine makers !